A Pharmacokinetic Evaluation of Free and DNA-Complexed Adriamycin: A Preliminary Study in Children with Malignant Disease
- 13 March 1978
- journal article
- research article
- Published by Wiley in Acta Pharmacologica et Toxicologica
- Vol. 42 (3) , 212-218
- https://doi.org/10.1111/j.1600-0773.1978.tb02192.x
Abstract
The pharmacokinetics of adriamycin given as free and in DNA-complexed form was compared in six children with malignant disease. The two types of adriamycin were given to the same child at 3–4-week intervals, thereby excluding genetic variations when comparing the results. Plasma and urine were collected during and after the drug infusion, and the drug concentrations were measured by means of a sensitive fluorimetric procedure. The study shows that one obtains: 1. a much higher plasma concentration of adriamycin when it is given in the complexed form. 2. a lower urine excretion of adriamycin and fluorescent metabolites when adriamycin is administered as the DNA-complex.Keywords
This publication has 6 references indexed in Scilit:
- Lysosomotropic agentsBiochemical Pharmacology, 1974
- Experimental leukemia chemotherapy with a “lysosomotropic” adriamycin-DNA complexPublished by Elsevier ,1974
- Pharmacokinetics and metabolism of adriamycin in manClinical Pharmacology & Therapeutics, 1973
- Daunorubicin metabolism in acute nonlymphocytic leukemiaClinical Pharmacology & Therapeutics, 1972
- Chemotherapy through Lysosomes with a DNA-Daunorubicin ComplexNature New Biology, 1972